Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Soleno Therapeutics Inc 100 MARINE PARKWAY SUITE 400 REDWOOD CITY CA 94065 USA

www.soleno.life Employees: 92 P: 650-213-8444 F: 650-213-8383

Sector:

Medical

Description:

Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief. Soleno Therapeutics Inc., formerly known as Capnia Inc., is based in Vancouver, Canada.

Key Statistics

Overview:

Market Capitalization, $K 2,175,255
Enterprise Value, $K 2,087,325
Shares Outstanding, K 53,710
Float, K 50,273
% Float 93.60%
Short Interest, K 11,472
Short Float 21.36%
Days to Cover 5.74
Short Volume Ratio 0.35
% of Insider Shareholders 6.40%
% of Institutional Shareholders 97.42%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -175,850 K
Last Quarter Sales, $ 66,020 K
Last Quarter Net Income, $ 26,010 K
EBIT, $ -89,270 K
EBITDA, $ -87,280 K

Growth:

1-Year Return -18.93%
3-Year Return 2,041.71%
5-Year Return -11.88%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 58.29%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.47 on 11/04/25
Next Earnings Date 02/26/26 [--]
Earnings Per Share ttm -1.84
EPS Growth vs. Prev Qtr 622.22%
EPS Growth vs. Prev Year 125.68%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 08/26/22

SLNO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 10.81
Price/Earnings to Growth N/A
Return-on-Equity % -25.88%
Return-on-Assets % -19.84%
Profit Margin % 0.00%
Debt/Equity 0.10
Price/Sales 19.69
Price/Cash Flow N/A
Price/Book 4.39
Book Value/Share 9.31
Interest Coverage -763.57
60-Month Beta -3.16
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar